Predictors of mediastinal staging and usefulness of pet in patients with stage IIIA (N2) or IIIB (N3) lung cancer.
José Antonio GullónManuel A VillanuevaAndrés A Sánchez-AntuñaManuel R RodríguezFernando Álvarez-NavascuesJesús AllendeManuel A Martínez-MuñizJosé M García-GarcíaPublished in: The clinical respiratory journal (2020)
In NSCLC, in locoregional disease radiographic staging by CT or PET predict the existence of N2/N3 mediastinal disease, but negative and positive predictive values of both imaging techniques are not adequate, so EBUS-TBNA samples should be taken in all lymph nodes with a diameter greater than 5 mm, regardless of PET findings.
Keyphrases
- lymph node
- pet ct
- positron emission tomography
- computed tomography
- sentinel lymph node
- neoadjuvant chemotherapy
- pet imaging
- small cell lung cancer
- high resolution
- contrast enhanced
- magnetic resonance imaging
- dual energy
- image quality
- advanced non small cell lung cancer
- ultrasound guided
- magnetic resonance
- optic nerve